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TO THE EDITOR
Hidradenitis suppurativa (HS; OMIM
142690) is an aggressive, chronic in-
flammatory skin disease that presents
with painful boils, cysts, and abscesses
in flexural areas, commonly resulting in
the formation of sinus tracts and scars. It
is a clinically heterogeneous, post-pub-
ertal condition that affects B1% of
Europeans (Revuz et al., 2008) and it
is associated with smoking (Konig et al.,
2009) and obesity (Rompel and Petres,
2000). In some families, the condition
has been shown to follow an autosomal
dominant inheritance pattern (Fitzsim-
mons and Guilbert, 1985; Von der
Werth et al., 2000). Mutations have
recently been reported in Presenilin-1
(PSEN1), Presenilin Enhancer-2 (PSENEN),
and Nicastrin (NCSTN) (Wang et al.,
2010), encoding three of four (the other
being Anterior Pharynx Defective-1,
APH1) proteins integral to g-secretase.
This is an endoprotease complex that
catalyses intramembrane cleavage of
membrane proteins, such as amyloid
precursor protein and Notch receptors
(De Strooper et al., 1999; De Strooper
et al., 1998). In this report, we describe
mutations in PSENEN and NCSTN,
which to our knowledge are previously
unreported, in two from seven pedi-
grees highlighting further locus hetero-
geneity in HS.
We recruited 53 individuals from
seven multigenerational pedigrees, in
whom HS was inherited as an auto-
somal dominant trait. All individuals
were of British origin. A history of five
or more painful or discharging nodules,
cysts, or abscesses in areas frequently
affected by HS (axilla, chest, groin,
buttocks, and thighs) was required for
diagnosis (Von der Werth et al., 2000).
Twenty-seven of the 53 individuals
recruited met this criteria. All subjects
provided full written consent, and the
study was conducted in accordance
with the Declaration of Helsinki prin-
ciples and approved by the East London
Research Ethics Committee 2 (reference
09/H0704/50).
DNA was extracted from saliva or
venous blood. All coding regions of
NCSTN (17 exons), PSEN1 (10 exons),
and PSENEN (3 exons) were amplified
by PCR using exon flanking intronic
primers and Sanger sequenced in 19
affected individuals, one or more from
each of the seven pedigrees. Sequen-
cing revealed a heterozygous single-
nucleotide insertion in PSENEN
(c.66_67insG) and a single-nucleotide
substitution in the NCSTN exon 9/
intron 9 donor splice site (c.1101þ 1
G4A) in each of two pedigrees. In-
dividuals II:2 and III:1 from pedigree 1
(Figure 1) were both heterozygous for
the c.66_67insG insertion in PSENEN
(Figure 1). The insertion is predicted to
lead to a frameshift and an altered
protein product (p.Phe23ValfsX98). The
mutation was absent in unaffected
family members (Figure 1, II:1, III:2)
and 200 control chromosomes of Eur-
opean ancestry. Sequencing of PSENEN
cDNA, generated from lymphoblast
mRNA (Ribopure extraction and cDNA
Reverse transcription kits, Applied Bio-
systems, Carlsbad, CA) from venous
blood, confirmed the presence of the
c.66_67insG variant; however, mRNA
expression, analyzed via reverse tran-
scription-PCR, revealed a marked reduc-
tion in PSENEN expression compared
with control samples (Figure 1) suggest-
ing that the mutant transcript is subject
to nonsense-mediated decay.
Both affected individuals from pedi-
gree 1 developed boils and abscesses in
their axillae, under their breasts, and in
their groins from the age of 15 years.
Individual III:1 was more severely
affected, having additional lesions over
her buttocks with resultant scarring and
sinus tract formation. They had a body
mass index of 33 (II:2) and 23 (III:1) and
had never smoked. Individual II:2 felt
that her symptoms worsened around
menstruation, whereas her mother,
III:2, noticed no cyclical change. On
examination, III:2 had light macular
hyperpigmentation in her axillae and
groins, and II:2 had very mild hyper-
pigmentation in the groin.
The proband from Pedigree 2
(Figure 2, III:1) was heterozygous for
a single-nucleotide substitution in
NCSTN (c.1101þ1 G4A; Figure 2).
The substitution is of the first base of
intron 9 in the highly conserved donor
splice site. However, no variant tran-
script was detected, and expression
levels of NCSTN in III:1 were observed
to be significantly lower than wild-type
controls (Figure 2), again suggesting
that this HS allele is subject to non-
sense-mediated decay. The mutation
was absent in his unaffected mother
(Figure 2, II:4), but no other affected
individuals were available for analysis.
The variant was not observed in 200
control chromosomes of European an-
cestry. Individual III:1 from pedigree 2
(Figure 2) reported boils and abscesses
in his axillae, suprapubic area, groin,
buttocks, thighs, and neck, all asso-
ciated with scarring and sinus tract
formation, from the age of 16 years.
He had a body mass index of 30 and a
15 pack-year smoking history.
Our results provide further evidence
that mutations resulting in haploinsuffi-
ciency of the g-secretase genes, NCSTN
and PSENEN, are involved in the patho-
genesis of some familial cases of HS. To
our knowledge, these findings have not
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previously been reported in Caucasian
individuals. These results indicate the
involvement of g-secretase in the devel-
opment of HS, which is further supported
by the development of cysts in g-secre-
tase-deficient mice (Pan et al., 2004). g-
Secretase is involved in the cleavage of a
wide array of transmembrane proteins;
however, it is noteworthy that the hair
follicle and sebaceous glands of mice
deficient in g-secretase are phenotypi-
cally identical to those of mice deficient
in Notch 1 and 2 (Pan et al., 2004),
potentially indicating the involvement of
the Notch cell signalling pathway in HS.
The binding of ligands to the extracellular
domain of Notch receptors induces g-
secretase-driven cleavage of the intracel-
lular domain which, in the nucleus,
affects gene expression (Oswald et al.,
2001). Our investigations highlight the g-
secretase–Notch pathway as a potential
therapeutic target in HS. However, it is
notable that screening ofNCSTN, PSEN1,
and PSENEN did not reveal mutations in
five of the seven pedigrees. These HS
pedigrees may therefore represent HS
alleles comprising non-coding or unde-
tected coding variants, represent pheno-
copies of HS, or be explained by further
locus heterogeneity in HS. Further loci
may include genes encoding other pro-
teins involved in the g-secretase–Notch
pathway. Investigations of additional
familial and sporadic cases are required
to establish the contributions of g-secre-
tase alleles in HS and identify further
genes underlying this debilitating disease.
The pathophysiological mechanisms un-
derlying HS may also provide insight into
the basis of more common conditions
such as acne vulgaris.
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Figure 1. Clinical and genetic findings in pedigree 1. (a) Pedigree 1, showing affected individuals II:2 and
III:1; (b) sequence from Presenilin Enhancer-2 (PSENEN) exon 3, showing c.66_67insG (arrow) in
genomic DNA from III:1 and wild-type sequence in unaffected II:1; (c) (i) individual III:1, inflamed
nodules, abscesses, fistulae, and scarring; (ii) individual II:2, multiple open comedones and an
inflammatory nodule on the background of patchy, macular hyperpigmentation; (d) reverse transcription-
PCR (RT-PCR), showing reduced expression of mRNA in affected individual III:1 compared with
unaffected control (error bar: mean±SD).
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Figure 2. Clinical and genetic findings in pedigree 2. (a) Pedigree 2, showing affected individuals
III:1 and III:2; (b) sequence from the end of Nicastrin (NCSTN) exon 9 showing a single-nucleotide
substitution (adenine for a guanine, see arrow) (c.1101þ1 G4A) at the first base of the donor splice
site (line marks the end of the exon) in affected individual III:1. No substitution can be seen in the
unaffected individual (II:4); (c) reverse transcription-PCR (RT-PCR), showing reduced expression of mRNA
in affected individual III:1 compared with control (error bar: mean±SD).
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TO THE EDITOR
Acne inversa (AI; also known as
hidradenitis suppurativa; OMIM
#142690) is an autosomal dominantly
inherited skin disorder characterized by
recurrent draining sinuses and ab-
scesses with subsequent scarring and
chronic seepage. It mainly affects the
scalp, neck, the axillae, perineum, and
inframammary regions, which may lead
to social embarrassment and have a
profound impact on the quality of life.
Its prevalence has been estimated to be
1–4% (Danby and Margesson, 2010).
Our previous studies have already
discovered that the genetic locus
responsible for AI is located at chromo-
some 1p21.1–1q25.3 by genome-
wide linkage scan in a four-generation
Chinese family (Gao et al., 2006).
Recently, exome sequencing has
been demonstrated to be a powerful
and cost-effective strategy for identify-
ing the responsible genes of rare mono-
genic disorders (Ng et al., 2009, 2010;
Hoischen et al., 2010). Here, we
subjected the exomes of two affected
(II4 and III8) and an unaffected (III7)
individual in our previously mapped
kindred (Family 1) to exome sequen-
cing. Informed consent was obta-
ined from all sequenced individuals.
This study was approved by the ethics
committee of Anhui Medical University
and was conducted according to
Declaration of Helsinki principles.
Exome capture was carried out using
Agilent SureSelect Human All Exon Kit
(in solution; Santa Clara, CA) guided
by the manufacturer’s protocols. Each
captured library was then loaded on
Hiseq2000 platform (Illumina, San Diego,
CA) and paired-end sequencing was
performed, with read lengths of 90bp,
providing at least 50 average depths for
each sample. Raw image files were
processed by Illumina Basecalling
Software 1.7 (San Diego, CA) for base-
calling with default parameters. Sequence
reads in each individual were aligned to
human reference genome builds hg18
using SOAPaligner 2.20 (Li et al., 2009b).
The consensus genotypes in target regions
were called by using SOAPsnp(v1.03)
(Li et al., 2009a).
On average, 10.36Gb of sequence
was generated per individual as paired-
end, 90-bp reads. After discarding the
reads that had duplicated start sites, we
achievedB50-fold coverage of the 2.2-
Gb mappable, targeted exome defined
by RefSeq genes (Pruitt et al., 2007).
On average, 87.4% of the exome was
covered at least 10-fold, and 42,678
genetic variants were identified per
individual, including 34,570 nonsynon-
ymous changes.
To distinguish potentially patho-
genic mutations from other variants,
we focused on nonsynonymous variants
and splice acceptor/donor site muta-
tions (SS), anticipating that synonymous
variants would be far less likely to be
pathogenic. We also presumed that the
variants responsible for AI would be
rare and therefore likely to be absent in
general population. A novel variant wasAbbreviation: AI, acne inversa
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